Other forms of plasma phospho-tau such as p217-Tau and p231-Tau may perform better than pT181-Tau, especially in early stages of Alzheimer’s disease, but much work has to be done in this direction [31,32,33]. This evidence concerns the gene MAPT and Alzheimer disease.